Ignite Creation Date:
2024-05-05 @ 5:05 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00385931
Status:
COMPLETED
Last Update Posted:
2023-11-09
First Post:
2006-10-09
Brief Title:
Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Multi-centre Study to Evaluate the Effects of Valsartan and the Combination of Valsartan and Simvastatin on Blood Pressure Ambulatory and Std Cuff and on Biochemical Markers of Endothelial Function hsCRP MCP-1 Serum F2 Isoprostanes PAI-1 tPA PICP PIIINP MMP9 MMP1 TIMP 1 Safety and Tolerability
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess and compare the efficacy and safety of valsartan and the combination of valsartan and simvastatin in patients with high blood pressure and high cholesterol
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None